Filing Details

Accession Number:
0000920465-19-000025
Form Type:
4
Zero Holdings:
No
Publication Time:
2019-01-31 18:49:55
Reporting Period:
2019-01-29
Accepted Time:
2019-01-31 18:49:55
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
920465 La Jolla Pharmaceutical Co LJPC Biological Products, (No Disgnostic Substances) (2836) 330361285
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1646626 S Lakhmir Chawla C/O La Jolla Pharmaceutical Company,
4550 Towne Centre Court
San Diego CA 92121
Chief Medical Officer No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2019-01-29 800 $5.55 3,059 No 4 P Direct
Common Stock Acquisiton 2019-01-29 1,200 $5.57 4,259 No 4 P Direct
Common Stock Acquisiton 2019-01-30 800 $5.57 5,059 No 4 P Direct
Common Stock Acquisiton 2019-01-30 200 $5.57 5,259 No 4 P Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Direct
No 4 P Direct
No 4 P Direct
No 4 P Direct